RxDoctor Payments Data

Jonathan Menachem, MD

Advanced Heart Failure and Transplant Cardiology · Nashville, TNNPI 1245556554

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $52,119 of the $78,594 with a category attached, or 66.3%. Abbott accounts for 71.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $20,974 and has fallen 89.2% since, to $2,255 in 2025. Among advanced heart failure and transplant cardiology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,594in general payments, 2019–2025

Across 238 payments — averaging $330.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$56K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$9K
  • Medtronic$8K
  • Abiomed$5K
  • Impulse Dynamics (USA) Inc.$212
  • Cvrx, Inc.$74
  • plus $16 from 1 others

What the payments were for

  • Consulting fees$8,32411%
  • Speaking & faculty fees$52,11966%
  • Travel & lodging$10,45813%
  • Food & beverage$7,69310%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott188$56,180
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)13$9,476
Medtronic(2 entities)14$7,550
Abiomed16$5,086
Impulse Dynamics (USA) Inc.5$212
Cvrx, Inc.1$74
Heartflow, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,594 in reported general payments places this provider in the 90th percentile of 28 advanced heart failure and transplant cardiology providers in Tennessee.

See all advanced heart failure and transplant cardiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$42,868
Medicare patients
148
Services billed
342

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan25$48,188
EliquisApixaban17$20,872
Carvedilol16$213
Warfarin Sodium15$177
Spironolactone12$105
Furosemide11$68
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$36

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →